Nexium Buyers Seek New Trial In Pay-For-Delay Case

Law360, New York (January 2, 2015, 4:14 PM EST) -- A group of Nexium buyers has asked a Massachusetts federal court for a new trial over antitrust claims that AstraZeneca PLC and Ranbaxy Inc. used a patent settlement to delay the launch of a cheaper generic version of the heartburn treatment.

Both the direct purchaser and end payor classes of plaintiffs, as well as individual retailers pursuing the case, argued in a pair of Wednesday filings that they should get a new trial of their so-called pay-for-delay antitrust claims against the two drugmakers because of last-minute changes the court made to the jury questionnaire and instructions.

Just before closing arguments, U.S....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!